By: Juan Sebastian Chaves GilThe therapeutic use of cannabidiol (CBD) is a subject of controversy. While its application to treat various conditions such as...
A recently published Japanese study has yet again demonstrated CBD’s potential in epilepsy. This is the first study of this nature to be conducted in the...
Given the potential harm to a child's developing brain and the lack of available evidence, most Canadian pediatricians are reluctant to recommend medical cannabis...
BERWYN, Pa.–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder,...
DUBLIN–(BUSINESS WIRE)–The “Cannabis Pharmaceuticals Market Size, Share & Trends Analysis Report by Brand Type (Sativex, Epidiolex), by Region (North America, ... Read More
CARLSBAD, Calif. – Greenwich Biosciences, Inc. and its parent company GW Pharmaceuticals, a British company involved in the development and manufacturing of plant-derived...
